Browse Category

Financial News News 11 June 2025 - 5 September 2025

Crypto Shockwaves: Bitcoin’s Red September, Trump’s Token Turmoil & Stripe’s Blockchain Bombshell – Roundup Sep 4–5, 2025

Crypto Shockwaves: Bitcoin’s Red September, Trump’s Token Turmoil & Stripe’s Blockchain Bombshell – Roundup Sep 4–5, 2025

Key Facts Cryptocurrency Market Movements: Bitcoin’s Big Test and Altcoin Plays After riding high through the summer, Bitcoin entered September on shaky ground. Historically, September has been a notoriously weak month for BTC, and 2025 appears to be no exception. Bitcoin opened this week around $110K – its lowest in nearly two months – triggering déjà vu for traders aware…
AI Stock Frenzy: Nvidia’s Record Rally, Surprise Surges & Setbacks Rock Markets (Aug 28–29, 2025)

AI Stock Frenzy: Nvidia’s Record Rally, Surprise Surges & Setbacks Rock Markets (Aug 28–29, 2025)

Key Facts August 28, 2025 – AI Hype Hits New Heights Nvidia’s Big Beat and Market Rally: Thursday brought a euphoria of AI-driven gains on Wall Street. Nvidia’s blowout earnings (revenue up 56% year-on-year) confirmed that “demand related to AI technology remains strong,” even though Nvidia’s forecast excluded China due to export uncertainties Reuters Reuters. The chip leader’s shares dipped…
Bitcoin Whiplash, Trump’s Crypto Gambit & NFT Revival – All the Blockchain Bombshells (Aug 26–27, 2025)

Bitcoin Whiplash, Trump’s Crypto Gambit & NFT Revival – All the Blockchain Bombshells (Aug 26–27, 2025)

Major Developments in DeFi, NFT & Gaming DeFi momentum builds: The decentralized finance sector saw moderate growth during August’s last week, buoyed by climbing crypto prices. Total value locked in DeFi protocols rose about 3.3% to roughly $149.2 billion ts2.tech. Liquid staking leader Lido Finance led the pack with over $38.1B in assets staked ts2.tech, reflecting continued appetite for staking…
Bitcoin’s Record Run, DeFi Shockwaves & NFT Revival – Crypto News Roundup (Aug 23–24, 2025)

Bitcoin’s Record Run, DeFi Shockwaves & NFT Revival – Crypto News Roundup (Aug 23–24, 2025)

Aave’s token jumped ~19% in 24 hours to about $355 after Aug. 21 when it expanded to Aptos and reworked Aave V3 in Move, its first deployment beyond Ethereum. <li-Ethereum’s proto-danksharding (EIP-4844) went live on testnets, with activation expected in the next upgrade “Dencun” by end-2025 to enable cheaper data storage for rollups. Bitcoin traded around $115,000–$117,000, roughly quadrupling from…
AI Stock Frenzy Hits Turbulence: Tech Titans Tumble, Chip Wars Heat Up (Aug 21–22, 2025 Roundup)

AI Stock Frenzy Hits Turbulence: Tech Titans Tumble, Chip Wars Heat Up (Aug 21–22, 2025 Roundup)

During Aug 21–22, 2025, the Nasdaq Composite and the S&P 500 tech sector each fell roughly 2% by Wednesday. Ahead of Fed Chair Jerome Powell’s Jackson Hole address, traders de-risked amid hopes of rate cuts. An MIT study found 95% of companies see no returns on AI spending, and OpenAI CEO Sam Altman cautioned investors may be overexcited. Tech stocks…
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia’s Epic August 2025: Record AI Earnings, Next-Gen Chips & Game-Changing Deals

Nvidia reported Q2 FY2026 revenue around $45 billion, up about 50% year over year, with data-center revenue at a record pace and $26.3 billion in the year-ago quarter. Nvidia’s market capitalization briefly surpassed $4 trillion in mid-2025, underscoring investor enthusiasm for AI leadership. The Blackwell architecture, led by the flagship H200/B100 GPUs, is up to 30× faster than prior generations…
21 August 2025
AI Stocks Frenzy: Mega Deals, GPT-5 Hype and Bubble Warnings Fuel Aug 9–10 Market Buzz

AI Stocks Frenzy: Mega Deals, GPT-5 Hype and Bubble Warnings Fuel Aug 9–10 Market Buzz

AMD’s Q2 data-center chip sales rose 14% to $3.2 billion but missed forecasts, while Nvidia’s stock surged 73%. SMCI shares plunged 18% in one day after missing revenue targets and cutting guidance amid Nvidia delays and rising competition, erasing over $6 billion in value overnight. By Aug. 7–8, the AI-chip rally resumed as Nvidia and Broadcom hit all-time highs, and…
AI Stocks Frenzy: GPT-5 Hype, Record Highs & Billion-Dollar Bets Fuel Aug 8–9 Market Surge

AI Stocks Frenzy: GPT-5 Hype, Record Highs & Billion-Dollar Bets Fuel Aug 8–9 Market Surge

OpenAI launched GPT-5 on Aug. 7, 2025, touting expert-level capabilities and 700 million ChatGPT users. On Aug. 7, 2025, the U.S. Commerce Department began licensing Nvidia to export its H20 AI chips to China, reversing a ban and potentially restoring access to a huge market. AMD shares fell 5.1% and SMCI dropped 18.2% after Q2 data-center results disappointed, with AMD…
Generative AI Ethics Unveiled: Global Challenges, Case Studies, and the Race for Responsible AI

Generative AI Ethics Unveiled: Global Challenges, Case Studies, and the Race for Responsible AI

The European Union finalized the AI Act in 2024, with full applicability by 2026, classifying AI by risk and requiring high-risk systems to include transparency, human oversight, and clear labeling for AI-generated content including deepfakes. China enacted the Interim Measures for Generative AI Services in August 2023, requiring provider registration, alignment with core socialist values, labeling of AI-generated media, and…
High Seas Broadband Boom: Maritime VSAT & L-Band Services Market Set to Soar by 2032

High Seas Broadband Boom: Maritime VSAT & L-Band Services Market Set to Soar by 2032

The global maritime VSAT and L-band services market is forecast to reach about $12.4 billion by 2032, with a roughly 8.5% CAGR from 2024 to 2032. In 2024, VSAT-based connectivity accounted for about 77% of maritime satcom revenue, while L-band MSS accounted for about 23%. The maritime VSAT market is projected to grow from about $3.46 billion in 2024 to…
1 612 613 614

Stock Market Today

  • Oric Pharmaceuticals Shares Poised for 74% Upside as Biotech Innovation Draws Investor Attention
    January 23, 2026, 8:13 AM EST. Oric Pharmaceuticals (NASDAQ: ORIC) is gaining investor interest with a potential 74% upside from its current $12.05 share price, backed by partnerships with Pfizer, Bayer, and Johnson & Johnson. The clinical-stage biotech focuses on therapies addressing cancer treatment resistance, advancing candidates like ORIC-114 and ORIC-944 through early-stage trials. Despite a $1.17 billion market cap, Oric reports a negative EPS of -1.71 and free cash flow of -$70.7 million, reflecting typical high-risk biotech dynamics. With no dividends and a neutral RSI, stock momentum shows cautious optimism. Analysts rate ORIC with 14 buys and project a $21 average target price, suggesting substantial growth for investors able to tolerate the sector's inherent uncertainties.
Go toTop